Form:REGARD-NOD Main file v1.0


CDE IDCDE Description
* 2777Site participant ID (Go To: 423)
* 423EDRN Protocol ID (Go To: 422)
* 422EDRN Site ID (Go To: 5731)
* 5731Is there a waiver of consent for this study? (Go To: 5730)
 
Permissible Values (value):No (0)
 
 Yes (1)
 
 Unknown (99)
* 5730Status in related study (Go To: 421)
 
Permissible Values (value):Enrolled (1)
 
 Approached, but did not enroll (2)
 
 Eligible, but not approached (3)
 
 Other (95)
 
 Unknown (99)
   421EDRN Participant ID (Go To: 2915)
* 2915IRB version: (Go To: 1322)
   1322Hispanic or Latino (Are you Hispanic or Latino?) (Go To: 1315)
 
Permissible Values (value):No (0)
 
 Yes (1)
 
 Unknown (99)
   1315Race (What is your race? Check all that apply.) (Go To: 5729)
 
Permissible Values (value):White (1)
 
 Black or African-American (2)
 
 American Indian or Alaska Native (3)
 
 Asian (4)
 
 Native Hawaiian or other Pacific Islander (7)
 
 Other, specify: (97)
 
 Unknown (99)
   5729Race, alternate (includes ethnicity) (check all that apply) (Go To: 1294)
 
Permissible Values (value):White (1)
 
 Black or African-American (2)
 
 American Indian or Alaska Native (3)
 
 Asian (4)
 
 Hispanic (5)
 
 Native Hawaiian or other Pacific Islander (7)
 
 More than One Race (8)
 
 Other, specify: (97)
 
 Unknown (99)
   1294Race (Other, specify) (Go To: 3780)
* 3780Age at cohort entry: (Go To: 1320)
* 1320Gender (What is your gender?) (Go To: 4221)
 
Permissible Values (value):Male (1)
 
 Female (2)
 
 Other (95)
 
 Unknown (99)
* 4221Height (value): (Go To: 4222)
* 4222Height (unit): (Go To: 4928)
 
Permissible Values (value):cm (centimeters) (1)
 
 inches (2)
 
 Unknown (99)
* 4928Glycemic parameter or Parameter of Diabetes Mellitus (PDM), test type (Go To: 4929)
 
Permissible Values (value):Fasting blood glucose (FBG), mg/dL (1)
 
 Hemoglobin A1c (HbA1c), % (2)
 
 Random Blood Glucose (RBG), mg/dL (3)
 
 2h Post Glucose (PG), mg/dL (11.1 mmol/L) during OGTT (5)
* 4929Glycemic parameter or Parameter of Diabetes Mellitus (PDM), test result (Go To: 5736)
   5736Date the participant began taking anti-DM medications, as days since a reference date.. (Go To: 3156)
* 3156Ever diagnosed with diabetes by a doctor? (Go To: 5734)
 
Permissible Values (value):No (0)
 
 Yes (1)
 
 Unknown (99)
   5734Date of diabetes mellitus diagnosis, as days since a reference date (Go To: 3028)
* 3028Diagnosed with study-related cancer?: (Go To: 3896)
 
Permissible Values (value):No (0)
 
 Yes (1)
 
 Unknown (99)
   3896Date of cancer diagnosis, as days since a reference date (Go To: 5051)
   5051Diagnosis status (pancreatic) (Go To: 5878)
 
Permissible Values (value):Definite (1)
 
 Probable (2)
 
 Possible (3)
 
 Unknown (99)
   5878Pancreatic cancer located in head of pancreas? (Go To: 5879)
 
Permissible Values (value):No (0)
 
 Yes (1)
   5879Pancreatic cancer located in neck of pancreas? (Go To: 5880)
 
Permissible Values (value):No (0)
 
 Yes (1)
   5880Pancreatic cancer located in body of pancreas? (Go To: 5881)
 
Permissible Values (value):No (0)
 
 Yes (1)
   5881Pancreatic cancer located in tail of pancreas? (Go To: 5732)
 
Permissible Values (value):No (0)
 
 Yes (1)
   5732Pancreatic cancer location (Go To: 5738)
 
Permissible Values (value):Head (1)
 
 Neck (2)
 
 Body (3)
 
 Tail (4)
 
 Unknown (99)
   5738Diagnostic confirmation (SEER) (Go To: 5737)
 
Permissible Values (value):Positive histology (1)
 
 Positive cytology (2)
 
 Positive microscopic confirmation, method not specified (4)
 
 Positive laboratory test/marker study (5)
 
 Direct visualization without microscopic confirmation (6)
 
 Radiology and other imaging techniques without microscopic confirmation (7)
 
 Clinical diagnosis only (other than 5, 6, or 7) (8)
 
 Unknown whether or not microscopically confirmed; death certificate only (9)
   5737ICD-O Morphology code, pancreas (Go To: 5882)
 
Permissible Values (value):Adenocarcinoma (81403) (1)
 
 Mucinous (colloid) carcinoma (84803) (2)
 
 Duct cell carcinoma (85003) (3)
 
 Islet cell carcinoma (81503) (4)
 
 Insulinoma (81513) (5)
 
 Glucagonoma (81523) (6)
 
 Gastrinoma (81533) (7)
 
 Wilms tumor/nephroblastoma (89603) (8)
 
 Hemangiopericytoma (91503) (9)
 
 Cystadenocarcinoma (84403) (10)
 
 papillary cystic carcinoma (84521) (11)
 
 adenoacanthoma (85703) (12)
 
 pancreatoblastoma (89713) (13)
 
 Mixed islet cell and exocrine adenocarcinoma (81543) (14)
 
 Unknown (99)
   5882Cancer stage, summary (Go To: 5141)
 
Permissible Values (value):Stage I or II (1)
 
 Stage III (3)
 
 Stage IV (4)
 
 Unknown (99)
   5141Pancreatic T-stage, clinical (Go To: 5142)
 
Permissible Values (value):TX (7)
 
 T0 (9)
 
 Tis (10)
 
 T1 (11)
 
 T1a (14)
 
 T1b (15)
 
 T1c (16)
 
 T2 (20)
 
 T3 (30)
 
 T4 (40)
 
 Unknown (99)
   5142Pancreatic N-stage, clinical (Go To: 5143)
 
Permissible Values (value):NX (1)
 
 N0 (2)
 
 N1 (10)
 
 N2 (20)
 
 Unknown (99)
   5143Pancreatic M-stage, clinical (Go To: 5138)
 
Permissible Values (value):MX (1)
 
 M1 (10)
 
 Unknown (99)
   5138Pancreatic stage group, clinical (Go To: 3307)
 
Permissible Values (value):Stage 0 (0)
 
 Stage IA (11)
 
 Stage IB (14)
 
 Stage IIA (21)
 
 Stage IIB (25)
 
 Stage III (30)
 
 Stage IV (40)
 
 Unknown (99)
   3307Pancreatic T-stage, pathologic: (Go To: 3308)
 
Permissible Values (value):TX (7)
 
 T0 (9)
 
 Tis (10)
 
 T1 (11)
 
 T1a (14)
 
 T1b (15)
 
 T1c (16)
 
 T2 (20)
 
 T3 (30)
 
 T4 (40)
 
 Unknown (99)
   3308Pancreatic N-stage, pathologic: (Go To: 4874)
 
Permissible Values (value):NX (1)
 
 N0 (2)
 
 N1 (10)
 
 N2 (20)
 
 Unknown (99)
   4874Pancreatic M-stage, pathologic (Go To: 4875)
 
Permissible Values (value):M0 (1)
 
 M1 (10)
 
 Unknown (99)
   4875Stage group, pancreatic (Go To: 2782)
 
Permissible Values (value):Stage 0 (0)
 
 Stage IA (11)
 
 Stage IB (14)
 
 Stage IIA (21)
 
 Stage IIB (25)
 
 Stage III (30)
 
 Stage IV (40)
 
 Unknown (99)
   2782Cancer stage (SEER): (Go To: 4285)
 
Permissible Values (value):In situ (0)
 
 Localized only (1)
 
 Regional by direct extension only (2)
 
 Regional lymph nodes involved only (3)
 
 Regional by BOTH direct extension AND lymph node involvement (4)
 
 Regional, NOS (5)
 
 Distant site(s)/node(s) involved (7)
 
 Not applicable (8)
 
 Unknown/unstaged/unspecified/DCO (9)
* 4285Date of last follow-up or death, as days since a reference date (Go To: 5733)
* 5733Reason for end of follow-up (Go To: 1097)
 
Permissible Values (value):End of 3-year passive follow-up (1)
 
 Diagnosed with PDAC (2)
 
 Death (5)
 
 Data extraction prior to 3 years from index (6)
 
 Lost due to disenrollment in the health care system (7)
 
 Unknown (99)
   1097Comments (do not include any participant identifiers) (Go To: End of Form)